[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619195":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":29,"responsibleParty":65,"collaborators":20,"id":67,"slug":20,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":20,"enrollmentInfo":76,"targetDuration":20,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":20,"overallStatus":52,"whyStopped":20,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Société des Produits Nestlé (SPN)","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Acceptability and Tolerance Study of bolus tube feed with food blends","OTHER","Arm one will act as their own controls",[13],"Dietary Supplement: Tube feed",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIETARY_SUPPLEMENT","Tube feed","Dose intake and duration.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Sharan Saduera, BSc (Hons) Dietetics","CONTACT","+447557170649","sharan.saduera@uk.nestle.com",{"name":28,"role":24,"phone":20,"phoneExt":20,"email":20},"Sarah Durnan, PHD, BSc Nutrition Dietetics",[30,50],{"facility":31,"status":32,"city":33,"state":20,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Queen Medical Hospital Nutrition and Dietetics","NOT_YET_RECRUITING","Nottingham","NG7 2UH","United Kingdom","UK",{"type":38,"coordinates":39},"Point",[40,41],-1.15047,52.9536,{"lat":41,"lon":40},[44,48],{"name":45,"role":24,"phone":46,"phoneExt":20,"email":47},"Sarah Durnan, PHD Dietetics","07812277811","s.durnan@nhs.net",{"name":49,"role":24,"phone":20,"phoneExt":20,"email":20},"James Evans, BSc Dietetics",{"facility":51,"status":52,"city":53,"state":20,"zip":54,"country":35,"countryCode":36,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Dietetic Team 1st floor Kings Court 1, Charles Hastings Way,","RECRUITING","Worcester","WR5 1JR",{"type":38,"coordinates":56},[57,58],-2.22001,52.18935,{"lat":58,"lon":57},[61],{"name":62,"role":24,"phone":63,"phoneExt":20,"email":64},"Martha Roos, BSc","+447717530359","martha.roos@nhs.net",{"type":66,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100619195",false,"NCT07341464","Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends","Acceptability (Including Gastrointestinal Tolerance and Compliance) of a Paediatric and Adult Bolus Tube Feed With Food Blends","Blends","Inclusion Criteria:\n\n* Patients from 1 -15 years for children and 15 years and above for adults of requiring 1 or more bolus tube feed alongside their usual tube feed or home-made blended diet as part of their dietary management for disease related malnutrition.\n* Patients well-established and stable on current enteral tube feed or home-made blended diet.\n* Gastrostomy fed only.\n* Willingly given, written, informed consent from patient\u002Fcaregiver\n\nExclusion Criteria:\n\n* Inability to comply with the study protocol, in the opinion of the investigator.\n* Under 1 years of age\n* Patients who have a nasogastric and jejunal feeding tubes\n* Patients on total parenteral nutrition\n* Known food allergies to any ingredients listed in appendix 1.\n* Patients with significant renal or hepatic impairment\n* Participation in another interventional study within 2 weeks of this study.\n* Patients with known or suspected ileus or mechanical bowel obstruction","ALL","1 Year",{"count":77,"type":78},50,"ESTIMATED","INTERVENTIONAL",[81],"NA","This is a prospective acceptability study to evaluate the gastrointestinal tolerance and compliance of a bolus tube feed over a 28 -day period for up to 50 participants.\n\nThe enteral bolus formula is for the dietary management of patients with short bowel syndrome; intractable malabsorption; preoperative preparation of undernourished patients; inflammatory bowel disease; total gastrectomy; dysphagia; bowel fistulae; feeding intolerances, developmental disabilities, and disease related malnutrition.",[84,85],"Cerebral Palsy (CP)","Oncology","2026-01-06",{"date":88,"type":89},"2026-01-14","ACTUAL",{"date":91,"type":89},"2025-12-10",{"date":93,"type":78},"2026-11-11",{"name":5,"class":6},2]